NOT KNOWN FACTUAL STATEMENTS ABOUT SEMAGLUTIDE WEEK 1-6 BUNDLE

The demo accomplished the two its Major endpoints, with semaglutide two.four mg demonstrating statistically sizeable and top-quality enhancements in liver fibrosis without worsening of steatohepatitis, and also resolution of steatohepatitis without any worsening of liver fibrosis in those with MASH when compared with placebo.1The written content on